HealthSouth Corporation (HLS) Shares Bought by Personal Capital Advisors Corp
Personal Capital Advisors Corp increased its holdings in HealthSouth Corporation (NYSE:HLS) by 6.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 356,273 shares of the company’s stock after purchasing an additional 20,298 shares during the period. Personal Capital Advisors Corp owned approximately 0.36% of HealthSouth Corporation worth $16,513,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. First Mercantile Trust Co. boosted its holdings in HealthSouth Corporation by 18.8% in the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after purchasing an additional 430 shares in the last quarter. Acrospire Investment Management LLC boosted its holdings in HealthSouth Corporation by 64.7% in the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after purchasing an additional 1,100 shares in the last quarter. Advisor Group Inc. boosted its holdings in HealthSouth Corporation by 33.8% in the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after purchasing an additional 781 shares in the last quarter. Petrus Trust Company LTA bought a new stake in HealthSouth Corporation in the second quarter worth $210,000. Finally, HL Financial Services LLC bought a new stake in HealthSouth Corporation in the second quarter worth $213,000. Hedge funds and other institutional investors own 93.28% of the company’s stock.
HealthSouth Corporation (NYSE HLS) traded down 1.44% on Thursday, reaching $44.57. 111,448 shares of the company’s stock were exchanged. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71. The firm has a market cap of $4.40 billion, a PE ratio of 16.24 and a beta of 0.58. The firm’s 50-day moving average is $45.37 and its 200-day moving average is $45.56.
HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating analysts’ consensus estimates of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. During the same quarter last year, the firm posted $0.69 EPS. The company’s quarterly revenue was up 6.6% on a year-over-year basis. On average, equities analysts forecast that HealthSouth Corporation will post $2.71 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date is Friday, December 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 36.76%.
A number of equities research analysts recently issued reports on the stock. Stephens assumed coverage on shares of HealthSouth Corporation in a report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price objective for the company. Zacks Investment Research upgraded shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Royal Bank Of Canada reiterated a “buy” rating and issued a $55.00 price objective on shares of HealthSouth Corporation in a report on Wednesday, September 6th. KeyCorp reiterated a “hold” rating on shares of HealthSouth Corporation in a report on Thursday, September 7th. Finally, ValuEngine upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating in a report on Friday, July 7th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the stock. HealthSouth Corporation has a consensus rating of “Hold” and an average price target of $50.38.
In other news, CEO Mark J. Tarr sold 22,625 shares of HealthSouth Corporation stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the completion of the transaction, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company’s stock.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.